Raisa Lowe

Vice President, Head of CMC  • Arbor Biotechnologies

Raisa Lowe, MS, has significant experience in cell and gene therapy, monoclonal antibodies, protein therapeutics, vaccines, and small molecule therapeutics from her 30-year career in the Biopharmaceutical industry. Raisa joined Arbor Biotechnologies as VP, Head of CMC in 2022. Prior to Arbor, Ms. Lowe worked at Editas Medicine, Juno Therapeutics, Argos Therapeutics, and Novartis in a variety of roles including CMC, Quality and Regulatory. Ms. Lowe received her MS in Biotechnology from Johns Hopkins University

Also Speaking

Cynthia Pussinen

Former Chief Technical Officer • Spark Therapeutics

Troels Jordansen

Chief Executive Officer • GlycoStem

Karen Walker

Chief Technical Officer • Kyverna Therapeutics

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.